[1]
R. Noviyani, P. A. Indrayathi, I. N. G. Budiana, K. Suwiyoga, and S. Putri, “DIFFERENCE OF TUMOR MASS IN STADIUM IIB-IIIB SQUAMOUS CELL CERVICAL CANCER PATIENTS WHO UNDERWENT PACLITAXEL CISPLATIN AND PACLITAXEL CARBOPLATIN CHEMOTHERAPY AT SANGLAH HOSPITAL DENPASAR”, Int J Pharm Pharm Sci, vol. 9, no. 10, pp. 139–143, Nov. 2017.